Search research articles
Contact Us
Filters
Showing results (111-120 of 176) with videos related to
Page
of 18
Sort By:
Leukemia
|
October 15, 2016
Pre-transplant donor CD4<sup>-</sup> invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease
M-T Rubio, M Bouillié, N Bouazza, et al.
Leukemia
|
October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
M Robin, G F Sanz, I Ionescu, et al.
Journal of Internal Medicine
|
October 5, 2017
Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT
F Baron, A Ruggeri, E Beohou, et al.
Journal of Internal Medicine
|
October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
O Ringdén, M Labopin, B Sadeghi, et al.
Bone Marrow Transplantation
|
April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts
M Aljurf, J D Rizzo, M Mohty, et al.
Leukemia
|
September 6, 2013
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT
A Ruggeri, G Sanz, H Bittencourt, et al.
Bone Marrow Transplantation
|
June 26, 2010
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients
V Roland, C Bodet-Milin, A Moreau, et al.
Leukemia
|
August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty, W Jacot, C Faucher, et al.
Bone Marrow Transplantation
|
February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation
|
December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
P Chevallier, M Labopin, N Milpied, et al.
Page
of 18
Search research articles
Search
Showing results (111-120 of 176) with videos related to
Sort By:
Page
of 18
Leukemia
|
October 15, 2016
Pre-transplant donor CD4<sup>-</sup> invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease
M-T Rubio, M Bouillié, N Bouazza, et al.
Leukemia
|
October 1, 2010
Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
M Robin, G F Sanz, I Ionescu, et al.
Journal of Internal Medicine
|
October 5, 2017
Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT
F Baron, A Ruggeri, E Beohou, et al.
Journal of Internal Medicine
|
October 14, 2017
What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?
O Ringdén, M Labopin, B Sadeghi, et al.
Bone Marrow Transplantation
|
April 30, 2014
Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts
M Aljurf, J D Rizzo, M Mohty, et al.
Leukemia
|
September 6, 2013
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT
A Ruggeri, G Sanz, H Bittencourt, et al.
Bone Marrow Transplantation
|
June 26, 2010
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patients
V Roland, C Bodet-Milin, A Moreau, et al.
Leukemia
|
August 22, 2003
Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen
M Mohty, W Jacot, C Faucher, et al.
Bone Marrow Transplantation
|
February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants
J R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation
|
December 3, 2013
Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
P Chevallier, M Labopin, N Milpied, et al.
Page
of 18